Journal
CLINICAL LYMPHOMA
Volume 3, Issue 4, Pages 257-259Publisher
CANCER INFORMATION GROUP, LP
DOI: 10.3816/CLM.2003.n.008
Keywords
B cells; CD80; immunotherapy; non-Hodgkin's lymphoma; Primatized (R); rituximab